Insulin Prices Dropped. But Some Poor Patients Are Paying More.news2025-01-16T10:00:13+00:00January 16th, 2025|The New York Times|
How a Company Makes Millions Off a Hospital Program Meant to Help the Poornews2025-01-15T15:15:34+00:00January 15th, 2025|The New York Times|
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picksnews2024-11-28T02:32:29+00:00November 28th, 2024|The New York Times|
Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposalnews2024-11-26T21:15:23+00:00November 26th, 2024|The New York Times|
On Drug Prices, Harris Pushes for Deeper Cuts While Trump Offers Few Specificsnews2024-10-08T17:07:01+00:00October 8th, 2024|The New York Times|
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countriesnews2024-10-02T23:12:20+00:00October 2nd, 2024|The New York Times|
Biden Officials Stave Off Sticker Shock on Medicare Drug Premiumsnews2024-09-27T20:00:11+00:00September 27th, 2024|The New York Times|
F.T.C. Accuses Drug Middlemen of Inflating Insulin Pricesnews2024-09-20T19:16:14+00:00September 20th, 2024|The New York Times|
The State That Chose to Cover Obesity Drugs for Its Poor, but Not Its Own Employeesnews2024-08-30T14:12:23+00:00August 30th, 2024|The New York Times|
